Blog Detail

Zuellig Pharma Expands China Clinical-Trial Cold-Chain Capacity

Zuellig Pharma has strengthened its clinical-trial supply network in China through the acquisition of a specialised facility in Hangzhou. The site holds a Drug Distribution License and supports local sourcing of comparator drugs and concomitant medications for both domestic studies and multi-regional clinical trials.

The facility adds precision-controlled storage at 15–25°C, 2–8°C and -20°C, and connects with Zuellig Pharma’s Beijing depot and global network of more than 45 clinical depots. The investment is expected to reduce sourcing complexity for trial sponsors while improving compliant, in-market access to temperature-sensitive clinical supplies in one of Asia’s key biopharmaceutical regions.